AKI Risk with SGLT2 Inibitors? Maybe Not, Clinic Data Show AKI Risk with SGLT2 Inibitors? Maybe Not, Clinic Data Show

Despite FDA warnings of a possible increased risk for AKI with the SGLT2 inhibitors, a new analysis of two large databases finds no evidence of elevated risk.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news